HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,717,044 | +14.9% | 767,061 | +9.2% | 0.02% | +21.1% |
| Q2 2023 | $59,824,424 | +3.1% | 702,659 | +0.2% | 0.02% | -5.0% |
| Q1 2023 | $58,023,322 | +100106.1% | 701,245 | -4.8% | 0.02% | +17.6% |
| Q4 2022 | $57,904 | -99.9% | 736,229 | +2.5% | 0.02% | -15.0% |
| Q3 2022 | $53,164,000 | +19.2% | 718,151 | +5.0% | 0.02% | +25.0% |
| Q2 2022 | $44,591,000 | +13.2% | 684,132 | +9.8% | 0.02% | +33.3% |
| Q1 2022 | $39,389,000 | +34.1% | 623,097 | +12.5% | 0.01% | +33.3% |
| Q4 2021 | $29,383,000 | -5.8% | 553,956 | +25.3% | 0.01% | -10.0% |
| Q3 2021 | $31,206,000 | -8.8% | 442,078 | -13.9% | 0.01% | -9.1% |
| Q2 2021 | $34,203,000 | -38.9% | 513,249 | +1.8% | 0.01% | -42.1% |
| Q1 2021 | $55,964,000 | -2.7% | 504,105 | +4.1% | 0.02% | -9.5% |
| Q4 2020 | $57,488,000 | +41.1% | 484,103 | +3.7% | 0.02% | +23.5% |
| Q3 2020 | $40,729,000 | +8.0% | 466,824 | +10.8% | 0.02% | 0.0% |
| Q2 2020 | $37,726,000 | -10.3% | 421,278 | -0.2% | 0.02% | -22.7% |
| Q1 2020 | $42,057,000 | -15.0% | 421,970 | -2.0% | 0.02% | +22.2% |
| Q4 2019 | $49,491,000 | -17.8% | 430,743 | -9.8% | 0.02% | -21.7% |
| Q3 2019 | $60,212,000 | -11.5% | 477,369 | -15.6% | 0.02% | -11.5% |
| Q2 2019 | $68,070,000 | +0.7% | 565,658 | -26.8% | 0.03% | -3.7% |
| Q1 2019 | $67,587,000 | -33.6% | 772,626 | -24.1% | 0.03% | -41.3% |
| Q4 2018 | $101,850,000 | -31.4% | 1,018,059 | -21.5% | 0.05% | -19.3% |
| Q3 2018 | $148,514,000 | +15.0% | 1,296,188 | -10.0% | 0.06% | +9.6% |
| Q2 2018 | $129,193,000 | +13.8% | 1,440,600 | -7.2% | 0.05% | +10.6% |
| Q1 2018 | $113,541,000 | +22.1% | 1,551,969 | -3.1% | 0.05% | +20.5% |
| Q4 2017 | $93,002,000 | +19.0% | 1,601,253 | -8.1% | 0.04% | +14.7% |
| Q3 2017 | $78,173,000 | +13.8% | 1,742,281 | +0.1% | 0.03% | +6.2% |
| Q2 2017 | $68,702,000 | -0.3% | 1,739,734 | +2.4% | 0.03% | -3.0% |
| Q1 2017 | $68,943,000 | +2.0% | 1,699,353 | +1.1% | 0.03% | -2.9% |
| Q4 2016 | $67,592,000 | +5.6% | 1,681,390 | -4.9% | 0.03% | -2.9% |
| Q3 2016 | $63,995,000 | +22.3% | 1,767,360 | -2.1% | 0.04% | +16.7% |
| Q2 2016 | $52,324,000 | -5.1% | 1,804,922 | +14.5% | 0.03% | -9.1% |
| Q1 2016 | $55,130,000 | +18.0% | 1,576,066 | +8.7% | 0.03% | +13.8% |
| Q4 2015 | $46,728,000 | +3.5% | 1,449,350 | +3.8% | 0.03% | -3.3% |
| Q3 2015 | $45,149,000 | -15.2% | 1,396,859 | +8.5% | 0.03% | -9.1% |
| Q2 2015 | $53,261,000 | +3.1% | 1,287,739 | +11.9% | 0.03% | 0.0% |
| Q1 2015 | $51,679,000 | +47.2% | 1,150,479 | +22.6% | 0.03% | +43.5% |
| Q4 2014 | $35,109,000 | +14.9% | 938,175 | +7.2% | 0.02% | +4.5% |
| Q3 2014 | $30,553,000 | +13.7% | 874,935 | +14.9% | 0.02% | +15.8% |
| Q2 2014 | $26,873,000 | +8.4% | 761,696 | +0.1% | 0.02% | 0.0% |
| Q1 2014 | $24,793,000 | -21.6% | 760,777 | +1.3% | 0.02% | -24.0% |
| Q4 2013 | $31,627,000 | +6.7% | 750,685 | +1.0% | 0.02% | -3.8% |
| Q3 2013 | $29,643,000 | -0.3% | 743,306 | +3.4% | 0.03% | -7.1% |
| Q2 2013 | $29,728,000 | – | 718,921 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |